Achieve Life Sciences, Inc.

NASDAQ:ACHV

5 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 00000005.06218.1627.11629.88220.0955.49613.61625.53920.13120.13122.3928.254264.9620.0250.0258.7490.40812.15.118.916.64.51.1
Cost of Revenue 0.2280.2360.250.2550.2540.2820.2820000000000000005.223.69-0.6-0.8-0.6-0.5-0.35.5
Gross Profit -0.228-0.236-0.25-0.255-0.254-0.282-0.2825.06218.1627.11629.88220.0955.49613.61625.53920.13120.13122.3928.254264.9620.0250.0253.529-3.28212.75.919.517.14.8-4.4
Gross Profit Ratio 00000001111111111111110.403-8.0351.051.1571.0321.031.067-4
Reseach & Development Expenses 15.81430.07823.9666.8829.6745.8683.10114.78825.10846.22455.31739.94821.55318.48324.167.81927.14741.10224.49410.7067.6538.9575.2213.2595.610.511.611.27.20
General & Administrative Expenses 11.43610.7229.1287.8686.8546.9453.5318.93311.80510.6259.8927.79105.843.9613.2938,218.897,576.2765,570.0515,869.3313,009.6653,242.3423.313.955.786.557.23.812.23.5
Selling & Marketing Expenses 11.197000000000000000-8,210.671-7,568.7-5,564.481-5,863.462-3,006.655-3,239.10.0010.4330.72-0.050-0.0100
SG&A 11.43610.7229.1287.8686.8546.9453.5318.93311.80510.6259.8927.7916.235.843.9613.2938.2197.5765.575.8693.013.2423.3114.3836.56.57.23.82.23.5
Other Expenses 0-1.55-0.058-0.0490.1330.1260.1651.0631.9523.2260.120.1380000000000000.60.80.60.50.40.3
Operating Expenses 27.78740.833.09414.7516.52812.8136.63223.72136.91356.84965.20947.73927.78324.32328.12111.11235.36648.67930.06416.57610.66312.1998.5327.64112.717.819.415.59.83.8
Operating Income -27.25-40.8-33.094-14.75-16.528-12.813-6.632-21.192-18.753-29.466-35.327-25.987-22.287-14.745-2.465-6.263-15.235-26.287-21.809-16.576-10.638-12.1740.216-7.2330.9-11.90.11.6-5-8.2
Operating Income Ratio 0000000-4.186-1.033-1.087-1.182-1.293-4.055-1.083-0.097-0.311-0.757-1.174-2.642-0.063-425.526-486.9640.025-17.710.074-2.3330.0050.096-1.111-7.455
Total Other Income Expenses Net -2.565-1.55-0.0580.020.1330.126-7.023-1.471.9523.4933.3286.2547.394-4.9630.1170.211-0.125-0.1120.0040.2650.1710.4370.5244.250.611.10.80.30.1
Income Before Tax -29.815-42.35-33.152-14.73-16.395-12.687-13.634-20.129-16.801-26.24-31.849-21.098-14.673-15.5842.465-10.691-15.36-26.399-21.805-16.311-10.467-11.7370.742-2.3240.43-11.171.12.2-5.4-8.7
Income Before Tax Ratio 0000000-3.976-0.925-0.968-1.066-1.05-2.67-1.1450.097-0.531-0.763-1.179-2.642-0.062-418.684-469.4910.085-5.6910.036-2.190.0580.133-1.2-7.909
Income Tax Expense 0-0.475-0.25-0.069-0.254-0.126-3.051-1.063-1.952-3.493-3.478-6.546-7.614-3-3.011-2.059-2.172-2.735-0.712-0.265-0.171-0.1010.2-0.1770.47-0.730.10.50.50.2
Net Income -29.815-41.875-32.902-14.661-16.141-12.687-10.583-20.129-16.801-26.24-31.849-21.098-14.673-12.5845.476-4.204-13.063-23.551-21.097-16.311-10.467-11.6360.542-2.1470.4-11.211.7-5.9-8.9
Net Income Ratio 0000000-3.976-0.925-0.968-1.066-1.05-2.67-0.9240.214-0.209-0.649-1.052-2.556-0.062-418.684-465.4320.062-5.2580.033-2.1960.0530.102-1.311-8.091
EPS -1.5-3.95-4.05-5.39-39.15-72.29-441.47-1,478.66-1,413.63-3,189.89-4,772.1-3,432.8-3,318.18-3,938.651,905.36-1,677.57-13,971.3-25,323.97-27,363.19-30,260.84-23,106.18-33,726.961,844.14-8,873.711,914.85-51,612.94,608.297,906.98-27,699.53-41,784.04
EPS Diluted -1.5-3.95-4.05-5.39-39.15-72.29-441.47-1,474.98-1,413.63-3,189.89-4,772.1-3,432.8-3,318.18-3,938.651,905.36-1,677.57-13,971.3-25,323.97-27,363.19-30,260.84-23,106.18-33,726.961,844.14-8,873.711,914.85-51,612.94,608.297,906.98-27,699.53-41,784.04
EBITDA -27.022-40.8-33.094-14.495-16.528-12.8130.838-16.126-18.753-30-38.308-33.66-29.606-5.692-2.699-11.234-14.454-25.565-21.227-16.06-10.258-11.5930.474-11.1251.5-12.1-0.41.3-4.9-8
EBITDA Ratio 0000000-3.186-1.033-1.106-1.282-1.675-5.387-0.418-0.106-0.558-0.718-1.142-2.572-0.061-410.309-463.7390.054-27.240.124-2.373-0.0210.078-1.089-7.273